Re-Recognizing the Cellular Origin of the Primary Epithelial Tumors of the Liver

References

• Doherty MR, Cheon H, Junk DJ, et al. Interferon-beta represses cancer stem cell properties in triple-negative breast cancer. Proc Natl Acad Sci U S A. 2017;114(52):13792–13797. doi:10.1073/pnas.1713728114
   Web of Science ®Google Scholar
• Hu Z, Artibani M, Alsaadi A, et al. The repertoire of serous ovarian cancer non-genetic heterogeneity revealed by single-cell sequencing of normal fallopian tube epithelial cells. Cancer Cell. 2020;37(2):226–242. doi:10.1016/j.ccell.2020.01.003
   Web of Science ®Google Scholar
• Wu HJ, Chu PY. Role of Cancer stem cells in cholangiocarcinoma and therapeutic implications. Int J Mol Sci. 2019;20(17):4154. doi:10.3390/ijms20174154
   Web of Science ®Google Scholar
• Nagtegaal ID, Odze RD, Klimstra D, et al. WHO Classification of Tumours of the Digestive System. 5th ed. Lyon: International Agency for Research on Cancer; 2019:216–217.
   Google Scholar
• Hu AB, He XS, Cai JY, Zheng QC, Lei TN, Guo ZG. Hepatic differentiation of mouse ES cells into BE cells in vitro. Cell Biol Int. 2006;30(5):459–465. doi:10.1016/j.cellbi.2006.01.006
   Web of Science ®Google Scholar
• Terada T. Human ductal plate and its derivatives express antigens of cholangiocellular, hepatocellular, hepatic stellate/progenitor cell, stem cell, and neuroendocrine lineages, and proliferative antigens. Exp Biol Med. 2017;242:907–917.
   Web of Science ®Google Scholar
• Haruna Y, Saito K, Spaulding S, Nalesnik MA, Gerber MA. Identification of bipotential progenitor cells in human liver development. Hepatology. 1996;23(3):476–481. doi:10.1002/hep.510230312
   Web of Science ®Google Scholar
• Strick-Marchand H, Weiss MC. Embryonic liver cells and permanent lines as models for hepatocyte and bile duct cell differentiation. Mech Dev. 2003;120(1):89–98. doi:10.1016/S0925-4773(02)00335-0
   Web of Science ®Google Scholar
• Behbahan IS, Duan Y, Lam A, et al. New approaches in the differentiation of human embryonic stem cells and induced pluripotent stem cells toward hepatocytes. Stem Cell Rev. 2011;7(3):748–759. doi:10.1007/s12015-010-9216-4
   PubMed Web of Science ®Google Scholar
• Schmelzer E, Zhang L, Bruce A, et al. Human hepatic stem cells from fetal and postnatal donors. J Exp Med. 2007;204(8):1973–1987. doi:10.1084/jem.20061603
   PubMed Web of Science ®Google Scholar
• Dan YY, Riehle KJ, Lazaro C, et al. Isolation of multipotent progenitor cells from human fetal liver capable of differentiating into liver and mesenchymal lineages. Proc Natl Acad Sci U S A. 2006;103(26):9912–9917. doi:10.1073/pnas.0603824103
   PubMed Web of Science ®Google Scholar
• Xu J, Hu Y, Wang J, Zhou J, Zhang T, Yu H. Immunohistochemical characterization of hepatic stem cell-related cells in developing human liver. Front Med China. 2007;1(3):264–268. doi:10.1007/s11684-007-0050-2
   Google Scholar
• Iglesias BV, Centeno G, Pascuccelli H, et al. Expression pattern of glypican-3 (GPC3) during human embryonic and fetal development. HistolHistopathol. 2008;23(11):1333–1340.
   Web of Science ®Google Scholar
• Herrera MB, Bruno S, Buttiglieri S, et al. Isolation and characterization of a stem cell population from adult human liver. Stem Cells. 2006;24:2840–2850. doi:10.1634/stemcells.2006-0114
   PubMed Web of Science ®Google Scholar
• Lemaigre FP. Development of the biliary tract. Mech Dev. 2003;120(1):81–87. doi:10.1016/S0925-4773(02)00334-9
   Web of Science ®Google Scholar
• Vestentoft PS, Jelnes P, Hopkinson BM, et al. Three-dimensional reconstructions of intrahepatic bile duct tubulogenesis in human liver. BMC Dev Biol. 2011;11(56). doi:10.1186/1471-213X-11-56
   Web of Science ®Google Scholar
• Roskams T, Desmet V. Embryology of extra- and intrahepatic bile ducts, the ductal plate. Anat Rec. 2008;291(6):628–635. doi:10.1002/ar.20710
   Google Scholar
• Desmet VJ, Van Eyken P, Sciot R. Cytokeratins for probing cell lineage relationships in developing liver. Hepatology. 1990;12(5):1249–1251. doi:10.1002/hep.1840120530
   Web of Science ®Google Scholar
• Shah KD, Gerber MA. Development of intrahepatic bile ducts in humans. Immunohistochemical study using monoclonal cytokeratin antibodies. Arch Pathol Lab Med. 1989;113(10):1135–1138.
   Web of Science ®Google Scholar
• Lombard CA, Prigent J, Sokal EM. Human liver progenitor cells for liver repair. Cell Med. 2013;5(1):1–16. doi:10.3727/215517913X666459
   Google Scholar
• Carpino G, Renzi A, Franchitto A, et al. Stem/progenitor cell niches involved in hepatic and biliary regeneration. Stem Cells Int. 2016;2016:3658013. doi:10.1155/2016/3658013
   Web of Science ®Google Scholar
• Terada T. Development of extrahepatic bile duct excluding gall bladder in human fetuses: histological, histochemical, and immunohistochemical analysis. Microsc Res Tech. 2014;77(10):832–840. doi:10.1002/jemt.22406
   Web of Science ®Google Scholar
• Overi D, Carpino G, Cardinale V, et al. Contribution of resident stem cells to liver and biliary tree regeneration in human diseases. Int J Mol Sci. 2018;19:2917. doi:10.3390/ijms19102917
   PubMed Web of Science ®Google Scholar
• Roskams T, Cassiman D, De Vos R, Libbrecht L. Neuroregulation of the neuroendocrine compartment of the liver. Anat Rec a DiscovMol Cell Evol Biol. 2004;280(1):910–923. doi:10.1002/ar.a.20096
   PubMedGoogle Scholar
• Kanda N, Fukuda Y, Imoto M, Koyama Y, Nakano I, Urano F. Localization of synaptophysin immunoreactivity in the human liver. Scand J Gastroenterol. 1994;29(3):275–279. doi:10.3109/00365529409090476
   PubMed Web of Science ®Google Scholar
• Grozdanov PN, Yovchev MI, Dabeva MD. The oncofetal protein glypican-3 is a novel marker of hepatic progenitor/oval cells. Lab Invest. 2006;86(12):1272–1284. doi:10.1038/labinvest.3700479
   PubMed Web of Science ®Google Scholar
• Darwiche H, Petersen BE. Biology of the adult hepatic progenitor cell: “Ghosts in the machine.”. Prog Mol Biol Transl Sci. 2010;97:229–249.
   PubMed Web of Science ®Google Scholar
• Chaudhari P, Tian L, Deshmukh A, Jang -Y-Y. Expression kinetics of hepatic progenitor markers in cellular models of human liver development recapitulating hepatocyte and biliary cell fate commitment. Exp Biol Med. 2016;241(15):1653–1662. doi:10.1177/1535370216657901
   Web of Science ®Google Scholar
• Katoonizadeh A, Poustchi H. Adult hepatic progenitor cell niche: how it affects the progenitor cell fate. Middle East J Dig Dis. 2014;6(2):57–64.
   PubMedGoogle Scholar
• Carpino G, Cardinale V, Onori P, et al. Biliary tree stem/progenitor cells in glands of extrahepatic and intraheptic bile ducts: an anatomical in situ study yielding evidence of maturational lineages. J Anat. 2012;220(2):186–199. doi:10.1111/j.1469-7580.2011.01462.x
   PubMed Web of Science ®Google Scholar
• Alvaro D, Gaudio E. Biliary tree stem cell subpopulations. Hepatology. 2016;64:644. doi:10.1002/hep.28546
   Google Scholar
• Tomita H, Kanayama T, Niwa A, et al. Chapter 13 - the stem cells in liver cancers and the controversies. In: Zheng Y-W, editor. Stem Cells and Cancer in Hepatology. Academic Press; 2018:273–287.
   Google Scholar
• Nishikawa Y, Doi Y, Watanabe H, et al. Transdifferentiation of mature rat hepatocytes into bile duct-like cells in vitro. Am J Pathol. 2005;166(4):1077–1088. doi:10.1016/S0002-9440(10)62328-0
   Web of Science ®Google Scholar
• Doffou M, Adams G, Bowen WC, et al. Oct4 is crucial for transdifferentiation of hepatocytes to biliary epithelial cells in an in vitro organoid culture model. Gene Expr. 2018;18(1):51–62. doi:10.3727/105221617X15124876321401
   Google Scholar
• Zhu C, Dong B, Sun L, Wang Y, Chen S. Cell sources and influencing factors of liver regeneration: a review. Med Sci Monit. 2020;26:e929129. doi:10.12659/MSM.929129
   Web of Science ®Google Scholar
• Font-Burgada J, Shalapour S, Ramaswamy S, et al. Hybrid periportal hepatocytes regenerate the injured liver without giving rise to cancer. Cell. 2015;162(4):766–779. doi:10.1016/j.cell.2015.07.026
   PubMed Web of Science ®Google Scholar
• Banga A, Akinci E, Lucas V, et al. In vivo reprogramming of Sox9+ cells in the liver to insulin-secreting ducts. Proc Nat Acad Sci. 2012;109(38):15336–15341. doi:10.1073/pnas.1201701109
   Web of Science ®Google Scholar
• Tarlow BD, Pelz C, Naugler WE, et al. Bipotential adult liver progenitors are derived from chronically injured mature hepatocytes. Cell Stem Cell. 2014;15(5):605–618. doi:10.1016/j.stem.2014.09.008
   Web of Science ®Google Scholar
• Segal JM, Kent D, Wesche DJ, et al. Single cell analysis of human foetal liver captures the transcriptional profile of hepatobiliary hybrid progenitors. Nat Commun. 2019;10(1):3350. doi:10.1038/s41467-019-11266-x
   Web of Science ®Google Scholar
• Zabulica M, Jakobsson T, Ravaioli F, et al. Gene editing correction of a urea cycle defect in organoid stem cell derived hepatocyte-like cells. Int J Mol Sci. 2021;22(3):1217. doi:10.3390/ijms22031217
   Web of Science ®Google Scholar
• Zabulica M, Srinivasan RC, Vosough M, et al. Guide to the assessment of mature liver gene expression in stem cell-derived hepatocytes. Stem Cells Dev. 2019;28(14):907–919. doi:10.1089/scd.2019.0064
   Web of Science ®Google Scholar
• Lin Y, Fang ZP, Liu HJ, et al. HGF/R-spondin1 rescues liver dysfunction through the induction of Lgr5+ liver stem cells. Nat Commun. 2017;8(1):1175. doi:10.1038/s41467-017-01341-6
   Web of Science ®Google Scholar
• Sekiya S, Suzuki A. Hepatocytes, rather than cholangiocytes, can be the major source of primitive ductules in the chronically injured mouse liver. Am J Pathol. 2014;184(5):1468–1478. doi:10.1016/j.ajpath.2014.01.005
   Web of Science ®Google Scholar
• Schmelzer E, Wauthier E, Reid LM. The phenotypes of pluripotent human hepatic progenitors. Stem Cells. 2006;24:1852–1858. doi:10.1634/stemcells.2006-0036
   PubMed Web of Science ®Google Scholar
• Chao J, Zhao S, Sun H. Dedifferentiation of hepatocellular carcinoma: molecular mechanisms and therapeutic implications. Am J Transl Res. 2020;12(5):2099–2109.
   PubMed Web of Science ®Google Scholar
• Scesa G, Adami R, Bottai D. iPSC preparation and epigenetic memory: does the tissue origin matter? Cells. 2021;10(6):1470. doi:10.3390/cells10061470
   PubMed Web of Science ®Google Scholar
• Libbrecht L, De Vos R, Cassiman D, Desmet V, Aerts R, Roskams T. Hepatic progenitor cells in hepatocellular adenomas. Am J Surg Pathol. 2001;25(11):1388–1396. doi:10.1097/00000478-200111000-00006
   Web of Science ®Google Scholar
• Iyer A, Robert ME, Bifulco CB, Salem RR, Jain D. Different cytokeratin and neuronal cell adhesion molecule staining patterns in focal nodular hyperplasia and hepatic adenoma and their significance. Hum Pathol. 2008;39(9):1370–1377. doi:10.1016/j.humpath.2008.01.015
   Web of Science ®Google Scholar
• Schotanus BA, Kruitwagen HS, van den Ingh TS, et al. Enhanced Wnt/β-catenin and Notch signalling in the activated canine hepatic progenitor cell niche. BMC Vet Res. 2014;10:309. doi:10.1186/s12917-014-0309-1
   Web of Science ®Google Scholar
• Micsenyi A, Tan X, Sneddon T, Luo JH, Michalopoulos GK, Monga SP. Beta-catenin is temporally regulated during normal liver development. Gastroenterology. 2004;126:1134–1146. doi:10.1053/j.gastro.2003.12.047
   PubMed Web of Science ®Google Scholar
• Sempoux C, Balabaud C, Bioulac-Sage P. Pictures of focal nodular hyperplasia and hepatocellular adenomas. World J Hepatol. 2014;6:580–595. doi:10.4254/wjh.v6.i8.580
   Google Scholar
• Walther Z, Jain D. Molecular pathology of hepatic neoplasms: classification and clinical significance. Patholog Res Int. 2011;2011:403929. doi:10.4061/2011/403929
   Google Scholar
• Fonseca S, Hoton D, Dardenne S, et al. Histological and immunohistochemical revision of hepatocellular adenomas: a learning experience. Int J Hepatol. 2013;2013:398308. doi:10.1155/2013/398308
   Google Scholar
• Matthai SM, Ramakrishna B. Cancer stem cells in hepatocellular carcinoma - an immunohistochemical study with histopathological association. Indian J Med Res. 2015;142(4):391–398. doi:10.4103/0971-5916.169195
   Web of Science ®Google Scholar
• Xiang Y, Yang T, Pang B, Zhu Y, Liu Y. The progress and prospects of putative biomarkers for liver cancer stem cells in hepatocellular carcinoma. Stem Cells Int. 2016;2016:7614971. doi:10.1155/2016/7614971
   Web of Science ®Google Scholar
• Berretta M, Cavaliere C, Alessandrini L, et al. Serum and tissue markers in hepatocellular carcinoma and cholangiocarcinoma: clinical and prognostic implications. Oncotarget. 2017;8(8):14192–14220. doi:10.18632/oncotarget.13929
   Google Scholar
• Ben-Porath I, Thomson MW, Carey VJ, et al. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet. 2008;40:499–507. doi:10.1038/ng.127
   PubMed Web of Science ®Google Scholar
• Feng J, Zhu R, Feng D, et al. Prediction of early recurrence of solitary hepatocellular carcinoma after orthotopic liver transplantation. Sci Rep. 2019;9:15855. doi:10.1038/s41598-019-52427-8
   Web of Science ®Google Scholar
• Fujii T, Zen Y, Harada K, et al. Participation of liver cancer stem/progenitor cells in tumorigenesis of scirrhous hepatocellular carcinoma-human and cell culture study. Hum Pathol. 2008;39:1185–1196. doi:10.1016/j.humpath.2007.12.010
   Web of Science ®Google Scholar
• Van Eyken P, Sciot R, Brock P, Casteels-van Daele M, Ramaekers FC, Desmet VJ. Abundant expression of cytokeratin 7 in fibrolamellar carcinoma of the liver. Histopathology. 1990;17:101–107. doi:10.1111/j.1365-2559.1990.tb00679.x
   Web of Science ®Google Scholar
• Feng J, Zhu R, Chang C, et al. CK19 and glypican 3 expression profiling in the prognostic indication for patients with HCC after surgical resection. PLoS One. 2016;11(3):e0151501. doi:10.1371/journal.pone.0151501
   PubMed Web of Science ®Google Scholar
• Feng J, Chen J, Zhu R, et al. Prediction of early recurrence of hepatocellular carcinoma within the Milan criteria after radical resection. Oncotarget. 2017;8(38):63299–63310. doi:10.18632/oncotarget.18799
   Google Scholar
• Kim H, Park C, Han KH, et al. Primary liver carcinoma of intermediate (hepatocyte-cholangiocyte) phenotype. J Hepatol. 2004;40:298–304. doi:10.1016/j.jhep.2003.10.023
   PubMed Web of Science ®Google Scholar
• Ding SJ, Li Y, Tan YX, et al. From proteomic analysis to clinical significance: overexpression of cytokeratin 19 correlates with hepatocellular carcinoma metastasis. Mol Cell Proteomics. 2004;3:73–81. doi:10.1074/mcp.M300094-MCP200
   PubMed Web of Science ®Google Scholar
• Lee KB. Histopathology of a benign bile duct lesion in the liver: morphologic mimicker or precursor of intrahepatic cholangiocarcinoma. Clin Mol Hepatol. 2016;22(3):400–405. doi:10.3350/cmh.2016.0105
   Google Scholar
• Bell D, Ranganathan S, Tao J, Monga SPS. Novel advances in understanding of molecular pathogenesis of hepatoblastoma: a Wnt/β-catenin perspective. Gene Expr. 2017;17(2):141–154. doi:10.3727/105221616X693639
   Google Scholar
• Tsuchida Y, Ikeda H, Suzuki N, et al. A case of well-differentiated, fetal-type hepatoblastoma with very low serum alpha-fetoprotein. J Pediatr Surg. 1999;34(12):1762–1764. doi:10.1016/S0022-3468(99)90307-X
   Web of Science ®Google Scholar
• Lee CT, Zhang L, Mounajjed T, Wu TT. High mobility group AT-hook 2 is overexpressed in hepatoblastoma. Hum Pathol. 2013;44(5):802–810. doi:10.1016/j.humpath.2012.08.003
   Web of Science ®Google Scholar
• Haas JE, Muczynski KA, Krailo M, et al. Histopathology and prognosis in childhood hepatoblastoma and hepatocarcinoma. Cancer. 1989;64(5):1082–1095. doi:10.1002/1097-0142(19890901)64:5<1082::AID-CNCR2820640520>3.0.CO;2-G
   PubMed Web of Science ®Google Scholar
• Zimmermann A. Variants of the hepatoblastoma tumor family. In: Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. Cham: Springer; 2017. doi:10.1007/978-3-319-26956-6_20
   Google Scholar
• Ruck P, Xiao JC, Kaiserling E. Small epithelial cells and the histogenesis of hepatoblastoma.Electron microscopic, immunoelectron microscopic, and immunohistochemical findings. Am J Pathol. 1996;148(1):321–329.
   Web of Science ®Google Scholar
• Cairo S, Armengol C, De Reyniès A, et al. Hepatic stem-like phenotype and interplay of Wnt/β-catenin and myc signaling in aggressive childhood liver cancer. Cancer Cell. 2008;14(6):471–484. doi:10.1016/j.ccr.2008.11.002
   PubMed Web of Science ®Google Scholar
• Alisi A, Cho WC, Locatelli F, Fruci D. Multidrug resistance and cancer stem cells in neuroblastoma and hepatoblastoma. Int J Mol Sci. 2013;14(12):24706–24725. doi:10.3390/ijms141224706
   Web of Science ®Google Scholar
• Zhang C, Liu Y, Wang Q, Chen H. Clinicopathological analysis of hepatoblastoma. J Clin Pediatr. 2015;33(10):912–913.
   Google Scholar
• Van Eyken P, Sciot R, Callea F, Ramaekers F, Schaart G, Desmet VJ. A cytokeratin-immunohistochemical study of hepatoblastoma. Hum Pathol. 1990;21(3):302–308. doi:10.1016/0046-8177(90)90231-S
   Web of Science ®Google Scholar
• Chattopadhyay S, Mukherjee S, Boler A, Sharma A, Biswas SK. Hepatoblastoma in the neonatal period: an unusual presentation. J Cytol. 2012;29(4):252–254. doi:10.4103/0970-9371.103945
   Web of Science ®Google Scholar
• Tanaka Y, Inoue T, Horie H. International pediatric liver cancer pathological classification: current trend. Int J Clin Oncol. 2013;18:946–954. doi:10.1007/s10147-013-0624-8
   Web of Science ®Google Scholar
• López-Terrada D, Alaggio R, de Dávila MT, et al. Towards an international pediatric liver tumor consensus classification: proceedings of the Los Angeles COG liver tumors symposium. Mod Pathol. 2014;27(3):472–491. doi:10.1038/modpathol.2013.80
   PubMed Web of Science ®Google Scholar
• Von Schweinitz D, Leuschner I, Glüer S, Pietsch T. Expression of cell adhesion molecules and common acute lymphoblastic leukaemia antigen in hepatoblastoma. Virchows Arch. 1996;429(4–5):235–241. doi:10.1007/BF00198339
   Web of Science ®Google Scholar
• Quartey B. Primary hepatic neuroendocrine tumor: what do we know now? World J Oncol. 2011;2(5):209–216. doi:10.4021/wjon341w
   Google Scholar
• Kim JM, Kim SY, Kwon CHD, et al. Primary hepatic neuroendocrine carcinoma. Korean J Hepatobiliary Pancreat Surg. 2013;17(1):34–37. doi:10.14701/kjhbps.2013.17.1.34
   Google Scholar
• Yang K, Cheng Y-S, Yang -J-J, Jiang X, Guo J-X. Primary hepatic neuroendocrine tumors: multi-modal imaging features with pathological correlations. Cancer Imaging. 2017;17:20. doi:10.1186/s40644-017-0120-x
   Web of Science ®Google Scholar
• Jo JM, Cho YK, Hyun CL, et al. Small cell carcinoma of the liver and biliary tract without jaundice. World J Gastroenterol. 2013;19(44):8146–8150. doi:10.3748/wjg.v19.i44.8146
   Web of Science ®Google Scholar
• Torbenson M. Fibrolamellar carcinoma: 2012 update. Scientifica. 2012;2012:743–790.
   Google Scholar
• Krings G, Ramachandran R, Jain D, et al. Immunohistochemical pitfalls and the importance of glypican 3 and arginase in the diagnosis of scirrhous hepatocellular carcinoma. Mod Pathol. 2013;26:782–791. doi:10.1038/modpathol.2012.243
   PubMed Web of Science ®Google Scholar
• Fragulidis GP, Chondrogiannis K, Vezakis A, et al. Neuroendocrine differentiation in embryonal type hepatoblastoma. Hepatol Res. 2013;43(3):320. doi:10.1111/j.1872-034X.2012.01070.x
   Web of Science ®Google Scholar
• He C, Yin HF, Liu P, et al. Clinicopathologic features of combined hepatic carcinoma. Chin j Pathol. 2013;42(12):824.
   Google Scholar
• Zhao M, Laissue JA, Zimmermann A. ‘Neuroendocrine’ differentiation in hepatocellular carcinomas (HCCs): immunohistochemical reactivity is related to distinct tumor cell types, but not to tumor grade. Histol Histopathol. 1993;8(4):617–626.
   Web of Science ®Google Scholar
• DeSano JT, Xu L. MicroRNA regulation of cancer stem cells and therapeutic implications. AAPS J. 2009;11(4):682–692. doi:10.1208/s12248-009-9147-7
   PubMed Web of Science ®Google Scholar
• Matsui WH. Cancer stem cell signaling pathways. Medicine. 2016;95(1 Suppl 1):S8–S19. doi:10.1097/MD.0000000000004765
   PubMed Web of Science ®Google Scholar
• Tarayrah L, Chen X. Epigenetic regulation in adult stem cells and cancers. Cell Biosci. 2013;3(1):41. doi:10.1186/2045-3701-3-41
   Web of Science ®Google Scholar
• Herrera SC, Bach EA. JAK/STAT signaling in stem cells and regeneration: from Drosophila to vertebrates. Development. 2019;146(2):dev167643. doi:10.1242/dev.167643
   PubMed Web of Science ®Google Scholar
• Varlakhanova NV, Cotterman RF, Devries WN, et al. Myc maintains embryonic stem cell pluripotency and self-renewal. Differentiation. 2010;80(1):9–19. doi:10.1016/j.diff.2010.05.001
   Web of Science ®Google Scholar
• Arsic N, Gadea G, Lagerqvist EL, et al. The p53 isoform Δ133p53β promotes cancer stem cell potential. Stem Cell Rep. 2015;4(4):531–540. doi:10.1016/j.stemcr.2015.02.001
   PubMed Web of Science ®Google Scholar
• Chapman-Rothe N, Curry E, Zeller C, et al. Chromatin H3K27me3/H3K4me3 histone marks define gene sets in high-grade serous ovarian cancer that distinguish malignant, tumour-sustaining and chemo-resistant ovarian tumour cells. Oncogene. 2013;19:4586–4592. doi:10.1038/onc.2012.477
   Web of Science ®Google Scholar
• Smith ZD, Shi J, Gu H, et al. Epigenetic restriction of extraembryonic lineages mirrors the somatic transition to cancer. Nature. 2017;549:543–547. doi:10.1038/nature23891
   PubMed Web of Science ®Google Scholar
• Bao S, Wu Q, Sathornsumetee S, et al. Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res. 2006;15:7843–7848. doi:10.1158/0008-5472.CAN-06-1010
   Web of Science ®Google Scholar
• Utermöhlen O, Krönke M. Survival of priceless cells: active and passive protection of embryonic stem cells against immune destruction. Arch Biochem Biophys. 2007;462:273–277. doi:10.1016/j.abb.2007.03.032
   PubMed Web of Science ®Google Scholar
• Lin VTG, Pruitt HC, Samant RS, et al. Developing cures: targeting ontogenesis in cancer. Trends Cancer. 2017;3(2):126–136. doi:10.1016/j.trecan.2016.12.007
   Web of Science ®Google Scholar
• Duraiswamy J, Kaluza KM, Freeman GJ, et al. Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumors. Cancer Res. 2013;73(12):3591–3603. doi:10.1158/0008-5472.CAN-12-4100
   PubMed Web of Science ®Google Scholar
• Hombach AA, Görgens A, Chmielewski M, et al. Superior therapeutic index in lymphoma therapy: CD30(+) CD34(+) hematopoietic stem cells resist a chimeric antigen receptor T-cell attack. Mol Ther. 2016;24(8):1423–1434. doi:10.1038/mt.2016.82
   PubMed Web of Science ®Google Scholar
• Stewart-Morgan KR, Petryk N, Groth A. Chromatin replication and epigenetic cell memory. Nat Cell Biol. 2020;22(4):361–371. doi:10.1038/s41556-020-0487-y
   PubMed Web of Science ®Google Scholar
• Zhang W, Feng J, Li Q. The replisome guides nucleosome assembly during DNA replication. Cell Biosci. 2020;10:37. doi:10.1186/s13578-020-00398-z
   Web of Science ®Google Scholar
• Wooten M, Ranjan R, Chen X. Asymmetric histone inheritance in asymmetrically dividing stem cells. Trends Genet. 2020;36(1):30–43. doi:10.1016/j.tig.2019.10.004
   Web of Science ®Google Scholar
• Reverón-Gómez N, González-Aguilera C, Stewart-Morgan KR, et al. Accurate recycling of parental histones reproduces the histone modification landscape during DNA replication. Mol Cell. 2018;72(2):239–249.e5. doi:10.1016/j.molcel.2018.08.010
   Web of Science ®Google Scholar
• Massa A, Varamo C, Vita F, et al. Evolution of the experimental models of cholangiocarcinoma. Cancers. 2020;12(8):2308. doi:10.3390/cancers12082308
   PubMed Web of Science ®Google Scholar
• D’Avola D, Villacorta-Martin C, Martins-Filho SN, et al. High-density single cell mRNA sequencing to characterize circulating tumor cells in hepatocellular carcinoma. Sci Rep. 2018;8(1):11570. doi:10.1038/s41598-018-30047-y
   PubMed Web of Science ®Google Scholar
• Zheng H, Pomyen Y, Hernandez MO, et al. Single-cell analysis reveals cancer stem cell heterogeneity in hepatocellular carcinoma. Hepatology. 2018;68(1):127–140. doi:10.1002/hep.29778
   PubMed Web of Science ®Google Scholar
• Ha K, Fujita M, Karlić R, et al. Somatic mutation landscape reveals differential variability of cell-of-origin for primary liver cancer. Heliyon. 2020;6(2):e03350. doi:10.1016/j.heliyon.2020.e03350
   Web of Science ®Google Scholar